SOPHiA GENETICS

SOPHiA GENETICS is a data-driven medicine company founded in 2011 in Switzerland by Jurgi Camblong, Pierre Hutter, and Lauranne Duquenne. Its cloud-native SOPHiA DDM platform standardizes and analyzes complex genomic and multimodal clinical data for oncology and rare disease diagnostics.

SOPHiA serves more than 780 hospitals and research institutions across 70+ countries. Its platform has analyzed over one million patient profiles worldwide.

The company went public on Nasdaq in July 2021 (SOPH), raising $234 million in its IPO. Jurgi Camblong serves as CEO. Headquarters are in Rolle, Switzerland with operations in Boston, Bidart, and Sydney.